Description of the medicine: Mildronat (Mildronatum)
MILDRONAT (Mildronatum). 3- (2, 2, 2-Trimethylhydrazinium) propionate; monohydrate.
Synonym: Trimethylhydrazinium propionate
White crystalline powder with a faint odor. Easily soluble in water, difficult to alcohol. Hygroscopic.
Mildronate is a quaternary ammonium compound. Has a partial structural similarity with carnitine.
The drug improves metabolic processes, increases efficiency.
It is proposed for use in adults with the aim of increasing endurance to physical exertion, reducing the phenomena of physical and mental stress, accelerating the rehabilitation of patients in the postoperative period. There is evidence of an improvement in the use of mildronate in patients with coronary heart disease complicated by heart failure, and for the prevention of ventricular arrhythmias.
Mildronate is prescribed orally (30 minutes after eating), as well as intravenously. For therapeutic purposes, Mildronate is taken orally at 0.25 g 2 to 4 times a day. 5 ml of a 10% solution (0.5 mg) is injected into a vein once a day. The course of treatment is 10 14 (20) days. If necessary, repeat it after a 2 - 3-week break.
To prepare for particularly intense physical exertion, Mildronate is prescribed according to special schemes.
Release form: capsules (yellow-red color) 0.25 g in a package of 10 capsules; 10% solution in ampoules of 5 ml (0.5 g) in a package of 5 ampoules.
Storage: List B. Capsules - in a dry place, ampoules - at a temperature not higher than + 5 'C.